Chargement en cours...
The efficacy and safety of oral disease-modifying therapies for relapsing-remitting multiple sclerosis: A systematic review
Background: Although widely used, first-line injectable medicines for the treatment of multiple sclerosis (MS) remain an issue of efficacy and adherence. Recently, new oral medications for MS have contributed to dramatic improvements in MS treatment. This study aims to evaluate the safety and effica...
Enregistré dans:
| Publié dans: | Curr J Neurol |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Tehran University of Medical Sciences
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8185589/ https://ncbi.nlm.nih.gov/pubmed/38011404 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18502/cjn.v19i3.5427 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|